Imperial Oil Limited Common Stock vs Moderna, Inc. — how do they compare? Imperial Oil Limited Common Stock trades at $129.6 (market cap $62.22B), while Moderna, Inc. trades at $225.49 (market cap $86.33B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| IMO | MRNA | |
|---|---|---|
Market Cap | $62.22B | $86.33B |
Volume | 560,544 | 13,361,426 |
Sector | Energy | Health |
52-Week High | $138.33 | $226.30 |
52-Week Low | $83.72 | $22.36 |
Enterprise Value | $63.13B | $82.48B |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 59 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $226.30, up 5.88% with strong technical momentum as it joins the Nasdaq-100 index. Despite beating Q2 2026 EPS estimates, the company faces fundamental challenges with negative profitability margins (-142.58% net income margin) and declining revenue from pandemic peaks. Technical indicators show bullish momentum with price above key support levels, while analyst sentiment remains divided with a $115.70 consensus target well below current levels.
The outlook balances Nasdaq inclusion benefits against valuation concerns after a 500% 2026 rally. Investment opportunity lies in the cancer vaccine pipeline growth, while risks include sustained profitability challenges and high valuation multiples (P/S 38.5) that may not justify current price levels given declining revenue trends.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →